Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

Optimal combination of immune cells for predicting outcomes in ESCC patients following neoadjuvant immunochemotherapy: Results from a prospective phase II trial.

Created on 12 Jul 2026

Authors

Peipei Wang, Yueyun Chen, Lin Lu, Yue Zheng, Xia Liu, Haibo Mao, Zexin Yi, Jiajun Li, Qin Zhang, Chengwu Zeng, Yong Wu, Zhenyu Ding, Cunte Chen

Published in

Genes & diseases. Volume 13. Issue 6. Pages 102040. Epub Jan 16, 2026.

PMID:
42437048
Bibliographic data and abstract were imported from PubMed on 12 Jul 2026.

Read full publication at:
Please sign in to see all details.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Reviewers' rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 7
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement